Well, if what is described in the article is correct - i.e., that is what MS are actually doing or intending
- then it would seem to be a form of "price gouging"
, which is illegal in some countries. It will be interesting to see how the governments in those countries view the actions of MS in regard to MS Office licencing in light of prevailing consumer protection regulations.
The more inept governments or those with weaker consumer protection legislation would probably just roll over and accept it, whereas others (perhaps including the UK, for example), could be unlikely to tolerate such monopolistic practices. We shall see.
What we have seen so far is that the US may have rather publicly set the bar very low here - e.g., the price-gouging initiated by Martin Shkreli (the overnight 5,000 percent increase in price of the drug Daraprim by Turing Pharmaceuticals) and then other drug companies apparently following suit, would seem to have gone unchallenged/uncorrected by commerce regulators.